» Authors » Raj Satyanarayana

Raj Satyanarayana

Explore the profile of Raj Satyanarayana including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 18
Citations 377
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Palmer W, Lee D, Burns J, Croome K, Rosser B, Patel T, et al.
Ann Hepatol . 2017 Apr; 16(3):402-411. PMID: 28425410
Introduction And Aim: Liver transplantation (LT) provides durable survival for hepatocellular carcinoma (HCC). However, there is continuing debate concerning the impact of wait time and acceptable tumor burden on outcomes...
2.
Sotello D, Hata D, Reza M, Satyanarayana R, Arunthari V, Bosch W
Case Rep Infect Dis . 2017 Feb; 2017:6958204. PMID: 28197350
We present a 49-year-old female with one year of intermittent fevers, chills, night sweats, and significant weight loss. Liver and lung biopsy showed evidence of a granulomatous process. Blood and...
3.
Reuben A, Tillman H, Fontana R, Davern T, McGuire B, Stravitz R, et al.
Ann Intern Med . 2016 Apr; 164(11):724-32. PMID: 27043883
Background: Acute liver failure (ALF) is a rare syndrome of severe, rapid-onset hepatic dysfunction-without prior advanced liver disease-that is associated with high morbidity and mortality. Intensive care and liver transplantation...
4.
Snipelisky D, Donovan S, Levy M, Satyanarayana R, Shapiro B
J Transplant . 2013 Aug; 2013:252838. PMID: 23956840
Introduction. While patients undergoing orthotopic liver transplantation (OLT) have high cardiovascular event rates, preoperative risk stratification may not necessarily predict those susceptible patients. Troponin T (TnT) may help predict patients...
5.
Pungpapong S, Aqel B, Koning L, Murphy J, Henry T, Ryland K, et al.
Liver Transpl . 2013 May; 19(7):690-700. PMID: 23696372
The safety, efficacy, and effect on immunosuppression levels of telaprevir (TVR) or boceprevir (BOC) in combination with peginterferon (PEG-IFN) and ribavirin (RBV) in recipients of liver transplantation (LT) with hepatitis...
6.
Dickson R, Pungpapong S, Keaveny A, Taner C, Ghabril M, Aranda-Michel J, et al.
Clin Transplant . 2011 Mar; 25(3):E345-55. PMID: 21429010
Liver transplant (LT) outcomes are reported to be improving in non-HCV recipients but not for those infected with HCV. Our aim was to evaluate graft survival and predictors of outcome...
7.
Begum R, Harnois D, Satyanarayana R, Krishna M, Halling K, Kim G, et al.
Liver Transpl . 2011 Jan; 17(1):83-7. PMID: 21254348
Although tumor transmission through liver transplantation (LT) is a rare occurrence, the consequences can be devastating, even when a very aggressive management approach is adopted. We report the case of...
8.
Hughes C, Dickson R, Krishna M, Willingham D, Satyanarayana R, Harnois D, et al.
J Int Assoc Physicians AIDS Care (Chic) . 2010 Apr; 9(2):87-93. PMID: 20357036
Patients coinfected with hepatitis C virus (HCV) and HIV undergoing liver transplantation (LT) are at risk of early, aggressive HCV recurrence. This study investigates the use of frequent protocol-driven biopsies...
9.
Grewal H, Willingham D, Nguyen J, Hewitt W, Taner B, Cornell D, et al.
Liver Transpl . 2009 Sep; 15(9):1028-35. PMID: 19718636
The use of donation after cardiac death (DCD) donors may provide a valuable source of organs for liver transplantation. Concerns regarding primary nonfunction (PNF) and intrahepatic biliary stricture (IHBSs) have...
10.
Ghabril M, Dickson R, Krishna M, Bonatti H, Aranda-Michel J, Keaveny A, et al.
Transplantation . 2009 Apr; 87(8):1174-9. PMID: 19384164
Background: The impact of using grafts from donor's age less than or equal to 13 years on adult hepatitis C virus (HCV) recipients in terms of survival and HCV recurrence...